Test Price
2,800 AED✅ Home Collection Available
CUBN Gene Megaloblastic Anemia Type 1 (Finnish Type) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين CUBN لفقر الدم الضخم الأرومات من النوع الأول (النمط الفنلندي) بتقنية NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary (الملخص التنفيذي)
دقة تشخيصية تصل إلى 99.9% عبر معالجة مخبرية معتمدة بمعايير ISO 9001:2015، مع خدمة سحب منزلي فاخرة بمستوى المستشفيات وتوجيه إكلينيكي بعد الفحص من أطباء مرخصين من هيئة الصحة.
✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
The CUBN Gene Megaloblastic Anemia Type 1 (Finnish Type) NGS Test sequences the entire coding region of the cubilin gene to detect pathogenic variants responsible for Imerslund-Gräsbeck syndrome, a rare autosomal recessive disorder causing selective vitamin B12 malabsorption. Performed on Whole Blood (EDTA), Extracted DNA or Dried Blood Spot (FTA Card) via Next-Generation Sequencing (NGS), it delivers definitive diagnosis, carrier status, and familial risk assessment with a turnaround of 3–4 weeks. يقدم هذا الفحص الجيني الشامل تحليلاً كاملاً لتسلسل جين CUBN للكشف عن الطفرات الممرضة المرتبطة بفقر الدم الضخم الأرومات من النوع الأول (النمط الفنلندي)، مما يساعد في التشخيص الدقيق وتقييم خطر الإصابة لدى أفراد العائلة.
| Feature | Our DHA-Certified Test | Closest Alternative |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) – full gene coverage with CNV detection | Sanger sequencing – limited to known mutations only |
| Turnaround Time | 3–4 weeks | 5–8 weeks |
| Variant Detection | SNVs, indels, copy number variants (CNVs) | Pre‑specified missense mutations only |
| Regulatory Backing | Federal Decree‑Law No. 41/2024, UAE PDPL, CDS Law 2026, ISO 9001:2015 | Non‑local lab; uncertain data privacy compliance |
Physician Insight & Safety Protocol
“A DNA result is a critical piece of the clinical puzzle; it must be interpreted in concert with hematologic indices and family history. As your DHA-licensed hematologist, I ensure that no treatment decision is made on genetic data alone without a thorough consultation.”
— Dr. PRABHAKAR REDDY, MBBS, MD (Hematology), DHA License No. 61713011
⚠️ Medication Warning: Do not discontinue any prescribed medication without consulting your doctor. A genetic test is not a substitute for clinical management.
Safety Exclusion Criteria & Emergency Red Flags
- Not indicated for acute hemolytic crisis or active bleeding; seek emergency care immediately.
- Do not delay life‑saving parenteral vitamin B12 therapy if severe macrocytic anemia with neurological signs is present.
- Mandatory pre‑test genetic counseling for minors; parental consent required under CDS Law 2026.
- Contact your physician urgently if you experience severe fatigue, shortness of breath, confusion, or palpitations.
Patient FAQ & Clinical Guidance
1. What makes this test superior to a standard vitamin B12 blood measurement?
This provides the definitive genetic aetiology of megaloblastic anemia by directly identifying pathogenic mutations in the CUBN gene — standard serum B12 assays cannot distinguish a genetic defect in cubilin‑mediated absorption from dietary deficiency.
2. هل يمكن إجراء هذا الفحص للأطفال؟
نعم، يمكن إجراء فحص جين CUBN للأطفال بعد استشارة وراثية وموافقة الوالدين وفقاً لقانون الخدمات السريرية الاتحادي 2026، حيث تُسحب عينة دم بسيطة في المنزل عبر خدمة السحب المنزلي المعتمدة.
3. How are results reported and what happens if a variant of uncertain significance (VUS) is found?
Results are delivered in 3–4 weeks with a detailed clinical report. If a VUS is identified, our DHA‑licensed genetic counselors provide a teleconsultation to explain its implications and recommend follow‑up family studies or functional testing.
This service complies with UAE Federal Decree‑Law No. 41 of 2024 (Genetic Health Regulations), CDS Law 2026 (Consent for Minors), UAE Personal Data Protection Law, and is delivered under ISO 9001:2015 Certification No. INT/EGQ/2509DA/3139. All medical advice is provided by DHA‑licensed professionals.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians